What You Should Know:
- Komodo Health announced its collaboration with Intercept Pharmaceuticals to power clinical research and new real-world evidence (RWE) with Komodo’s platform.
Leveraging Komodo’s tech platform and Healthcare Map, Intercept was able to conduct a retrospective real-world study on the long term outcomes for Ocaliva — a therapeutic for rare liver disease, primary biliary cholangitis (PBC).
Partnership Details
Intercept initially developed a traditional
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
CitiusTech Acquires Wilco Source to Expand Salesforce Capabilities for Healthcare & Life Sciences
What You Should Know:
- CitiusTech announced that it has acquired Wilco Source, an industry-leading Salesforce solutions company to expand its offerings in patient services, care management and digital front door.
- This strategic acquisition comes on the heels of Bain’s recently announced investment in CitiusTech valued above $1B. These strategic initiatives validate both CitiusTech’s track record of success and CEO Bhaskar Sambasivan ‘s strategic
Read More
PointClickCare & Pfizer Launches Real World Data Collaboration
What You Should Know:
- PointClickCare announced a collaboration with Pfizer Inc. to provide real-world insights for vulnerable populations at high risk of age-related disorders (including Cachexia) – further enhancing PCC’s mission to protect and support the senior population.
- With coverage approaching 70% of the long-term and post-acute care (LTPAC) market, PointClickCare is uniquely positioned to provide life sciences companies, like Pfizer, with outcomes-based evidence through
Read More
AI ‘s Role in Drug Discovery: Separating the Hype from the Hope
Forecasting the influence that artificial intelligence (AI)/machine learning technologies will have on the future of healthcare has created a cottage industry in the hype. From the overzealous aspirations of IBM’s Watson Health initiative to the inclusion of AI on Gartner’s 2021 Hype Cycle at the “Peak of Inflated Expectations,” so much noise has been made around AI/machine learning in healthcare that it can be difficult to appreciate the current impact of these technologies on drug discovery,
Read More
The Desire for Cost Savings Driving Key Trends in Healthcare Market
The healthcare market underwent significant changes during the pandemic as patients rethought how they received care, including opting for more telehealth and deferred elective procedures, but patient care is now normalizing as patients return to the office. However, payers are working to reduce the cost of care to reel in healthcare costs and keep premiums lower to remain competitive, driving key changes.
Ambulatory Surgery and Home Care
Surgeries are increasingly moving away from
Read More
Overcoming Ripple Effects of COVID-19 to Boost Patient Outcomes: 3 Insights
Fear of COVID-19 exposure isn’t the only thing holding patients back from seeking needed care during the pandemic. So are the complexities of navigating life after COVID-19—and it’s a struggle that physicians, who are overworked and burned out, can relate to as well.
Even as data indicates that consumer deferment of care—common during the first 18 months of the pandemic—has decreased, not all consumers have returned for care as soon as expected. In some instances, financial concerns
Read More
The Gains and Pains of Using AI in the Pharmaceutical Industry
The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster.
A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More
Should I Get Another Booster? How Doctors Can Help Patients Navigate the Next Phase of COVID-19
The general consensus is that COVID-19 in some form is here to stay. As people come to terms with this reality, primary care providers may be getting more questions from patients – especially older and immunocompromised ones – asking for advice on how to handle different situations. Should I get another booster? Can I start traveling? Is it OK to go to a wedding next weekend? How cautious do I need to be in social settings?
The answers to these questions aren’t always clear. A lot depends on
Read More
Prenuvo Raises $70M for Whole Body MRI Scans
What You Should Know:
- Prenuvo, an Redwood City, CA-based advanced, radiation-free whole body imaging for early detection of cancer and other diseases raises $70M in Series A equity and debt funding led by Felicis, with participation from existing investors including Tony Fadell, NYT bestseller author and founder of Nest; Dr. Timothy A. Springer, Lasker award recipient; Anne Wojcicki, CEO of 23&Me; Steel Perlot, with Eric Schmidt as chairman; entrepreneur Rande Gerber; and wellness
Read More
